A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Conditions:   Migraine;   Pain;   Nausea;   Vomiting;   Aura Interventions:   Drug: Arm 1: CL-H1T;   Drug: Arm 2: CL-H1T;   Drug: Arm 3: Sumatriptan Succinate 100 mg capsule;   Drug: Arm 4: Promethazine HCl 18.75 mg;   Drug: Arm 5: Promethazine HCl 37.5 mg;   Other: Placebo Sponsor:   Charleston Laboratories, Inc Recruiting

Source: ClinicalTrials.gov - March 18, 2019 Category: Research Source Type: clinical trials